Compare Hims and Hers Health Inc (HIMS) vs Prospect Capital Corporation (PSEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Prospect Capital Corporation — how do they compare? Hims and Hers Health Inc trades at $30.92 (market cap $6.55B), while Prospect Capital Corporation trades at $1.72 (market cap $974.22M). The key difference: Hims and Hers Health Inc is far larger — about 6.7× Prospect Capital Corporation's market cap, and Prospect Capital Corporation pays a 23.01% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and Prospect Capital Corporation for 78 Days on average.
| HIMS | PSEC | |
|---|---|---|
Market Cap | $6.55B | $974.22M |
Volume | 14,842,814 | 5,779,996 |
Sector | Health | Financials |
52-Week High | $62.76 | $3.05 |
52-Week Low | $14.52 | $1.72 |
Typical Hold Time | 21 Days | 78 Days |
Enterprise Value | $7.25B | $2.73B |
Dividend Yield | — | 23.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HIMS stock trades at $28.06, down 5.01% on the day, reflecting bearish technical signals and negative earnings surprises in recent quarters. The company reported strong revenue growth to $2.35 billion in 2025 but swung to a net loss of -$142 million in 2026, with profitability metrics deteriorating. Multiple securities class action lawsuits filed in October 2026 create significant legal overhangs, while analyst consensus remains cautiously optimistic with a $32.17 price target despite mixed fundamental performance.
The outlook is clouded by legal risks and profitability challenges, though the 15% upside to consensus target suggests potential recovery if execution improves. Key risks include ongoing litigation outcomes and the company's ability to return to sustainable profitability amid competitive pressures in the telehealth sector.
PSEC trades at $1.82, down 1.09% on the day, with a bearish technical signal from moving averages. The company reported negative revenue and net income for 2025, though it has beaten EPS estimates in recent quarters. Recent news highlights dividend declarations and management commentary on the firm's track record.
The outlook is clouded by financial volatility and a mixed analyst consensus. The primary opportunity is the high dividend yield, but risks include persistent negative profitability, portfolio contraction, and a majority of analysts rating the stock as Hold or Sell.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
Read more on PSEC →
